Plasmodium falciparum pre-erythrocytic stage antigen (No widely accepted abbreviation for this stage or target as a whole; individual antigens such as CSP (circumsporozoite protein) are abbreviated.)

Plasmodium falciparum pre-erythrocytic stage comprises sporozoites transmitted by Anopheles mosquitoes and the liver-stage forms that develop inside hepatocytes prior to initiating blood-stage infection. This phase involves key proteins such as circumsporozoite protein (CSP), cell-traversal protein for ookinetes and sporozoites (CelTOS), P52, and P36, which facilitate hepatocyte invasion, intracellular development, and immune evasion. Vaccines and therapeutics targeting these antigens aim to block the life cycle before parasite proliferation and the onset of malaria symptoms. The stage is a major focus of intervention development but is not itself a single molecular target; rather, it refers to the sum total of antigens expressed by the parasite in sporozoite and hepatic forms[2][3][6]. It is not a single gene/protein/molecule but a developmental phase containing multiple protein antigens, thus not suitable as a canonical molecular target. It is a primary focus for vaccine development (RTS,S/AS01 targets CSP)[6]. Most common molecular targets within this stage include CSP, CelTOS, P52, and P36[3][6]. Its main functions are hepatocyte invasion, immune evasion, and parasite multiplication in the liver[2]. Its disease role is essential for malaria infection and pathogenesis[2][6]. For structured molecular characterization, entries should point to specific pre-erythrocytic protein antigens (e.g., circumsporozoite protein), rather than the lifecycle stage as a whole.

Other names

Pre-erythrocytic Plasmodium falciparumLiver-stage Plasmodium falciparumExo-erythrocytic stage Plasmodium falciparumSporozoite stage Plasmodium falciparum

Induction of immune responses (antibody and T-cell) against parasite proteins (e.g., CSP) during the sporozoite and liver stages, blocking hepatocyte invasion and intrahepatic development, thereby preventing progression to blood stage infection by immune-mediated parasite elimination before erythrocyte invasion.